Research Programs

News Briefs

Publications
Events, Lectures & Workshops
Grants and Awards

Publications:

Feyruz Rassool, Ph.D. associate professor, Department of Radiation, is senior author on a paper with Sallmyr A, Fan J, Datta K, Kim KT, Grosu D, Shapiro P, and Small D, “Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML” Blood. 2008 Mar 15;111(6):3173-82. Epub 2008 Jan 11.

Ming T. Tan, Ph.D. professor, Department of Epidemiology and Preventive Medicine,, authored an article “Conditional Power in Clinical Trial Monitoring.” Wiley Encyclopedia of Clinical Trials, D'Agostino R, ed., Wiley-Interscience 2008.

Events, Lectures & Workshops:

Feyruz Rassool, Ph.D., associate professor, Department of Radiation, has an invited talk at the American Association for Cancer Research (AACR) on April 13 in a session entitled: A Paradigm Rift in Myelodysplastic Syndromes: New Insights Range from Bench to Bedside. The title of her presentation is: “Reactive oxygen species (ROS), DNA Damage and Repair Errors: A Model for Genomic Instability in Myelodysplastic Syndromes.”

New Grants and Awards:

Department of Defense Pre-Doc Award 2008

Erik Balzer (PI) -- Molecular alterations that reduce cotical containment of tubilin microtentacles and their impact on breast tumor metastasis; $97,200 Total
Edward Cho (PI) -- Elucidating the role of aberrant microtubule nucleation in breast cancer metastasis; $97,200 Total

DOD Concept Award 2008

Anne Hamburger, Ph.D. (PI) -- Negative regulation of ErbB Signaling in Breast Cancer by the ErbB3 Binding Protein Ebp1; $112,500 Total

International Association for the Study of Lung Cancer (IASLC) Fellowship Award

Margit Naomi Horiba, M.D. (PI), Martin J. Edelman, M.D. (Mentor) -- Myeloid derived suppressor cells in NSCLC. Influence of tumor bulk and COX-2; $80,000 Total

Maryland Technology Development Corporation (TEDCO)

Feyruz Rassool, Ph.D. (Co-PI), (PI-Baylin/JHU) -- Dissecting the genetic and epigenetic origins underlying tumorigenic potential of human embryonic and adult stem cells; $1.5M Total

Susan G. Komen for the Cure Research Grant

Geoffrey Girnun, Ph.D. (PI) -- Bioenergetic control of breast cancer growth by the transcriptional coactivation PGC1alpha; $450,000 Total

NIH/NCI

Edward A. Sausville, M.D., Ph.D. (Co-PI), Martin J. Edelman, M.D. (Co-Investigator)
Maria Baer, M.D. (Co-Investigator), Ivana Gojo, M.D. (Co-Investigator) -- U01-CA62487 (LaRusso) -- Early Clinical Trials of New Anti-Cancer Agents; $81,949 Total
Edward A. Sausville, M.D., Ph.D. (PI) -- Paul Calabresi Award for Clinical Oncology; $4,000,959 Total
Edward A. Sausville, M.D., Ph.D. (PI), Recommended for funding -- Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine: a Phase II trial with correlative biomarker endpoints (R21 Quick Trial); $750,000 Total

This page was last updated on: June 3, 2008.